teva pharmaceutical-sp adr
(TEVAN:Mexico Stock Exchange)
Last $497.00 MXN
Change Today 0.00 / 0.00%
Volume 0.0
As of 4:09 PM 05/20/13 All times are local (Market data is delayed by at least 15 minutes).
Audit Committee* - teva pharmaceutical-sp adr (TEVAN)
| Name (Connections) | Board Relationships | Title | Key Developments |
| Moshe Many Ph.D., M.D. | 40 Relationships | Vice Chairman, Vice Chairman of Scientific Advisory Committee, Member of Audit Committee and Member of Corporate Governance & Nominating Committee | |
| Ory Slonim | 16 Relationships | Director, Chairman of Corporate Governance & Nominating Committee, Member of Human Resources & Compensation Committee, Member of Audit Committee and Member of Corporate Responsibility Committee | |
| Joseph Nitzani | 16 Relationships | Statutory Independent Director, Chairman of Audit Committee, Member of Corporate Governance & Nominating Committee, Member of Human Resources & Compensation Committee, Member of Finance & Invesment Committee and Member of Corporate Responsibility Committee | |
| Dafna Schwartz | 40 Relationships | Statutory Independent Director, Chairman of Human Resources & Compensation Committee, Member of Audit Committee and Member of Corporate Responsibility Committee | |
| Erez Vigodman | 16 Relationships | Director, Member of Finance & Invesment Committee and Member of Audit Committee |
Nominating Committee* - teva pharmaceutical-sp adr (TEVAN)
| Name (Connections) | Board Relationships | Title | Key Developments |
| Moshe Many Ph.D., M.D. | 40 Relationships | Vice Chairman, Vice Chairman of Scientific Advisory Committee, Member of Audit Committee and Member of Corporate Governance & Nominating Committee | Teva Pharmaceutical Industries Limited Appoints Paul J. Sekhri as Group Executive Vice President, Global Business Development and Chief Strategy Officer 04/29/13 |
| Amir Elstein | 58 Relationships | Director, Chairman of Corporate Responsibility Committee, Member of Finance & Invesment Committee and Member of Corporate Governance & Nominating Committee | Teva Pharmaceutical Industries Limited Creates Global Specialty Medicines Group; Announces Executive Appointments 04/24/13 |
| Ory Slonim | 16 Relationships | Director, Chairman of Corporate Governance & Nominating Committee, Member of Human Resources & Compensation Committee, Member of Audit Committee and Member of Corporate Responsibility Committee | Teva Pharmaceutical Industries Limited Appoints Yoo Suk Hong as CEO of Teva-Handok 04/8/13 |
| Joseph Nitzani | 16 Relationships | Statutory Independent Director, Chairman of Audit Committee, Member of Corporate Governance & Nominating Committee, Member of Human Resources & Compensation Committee, Member of Finance & Invesment Committee and Member of Corporate Responsibility Committee | Teva Pharmaceutical Industries Limited Names Ichiro Kikushige as CEO of Teva Seiyaku, Japan 04/8/13 |
| Dan Propper | 28 Relationships | Director, Member of Human Resources & Compensation Committee and Member of Corporate Governance & Nominating Committee | Teva Pharmaceutical Industries Limited Appoints Dr. Arie Belldegrun to Board of Directors 02/11/13 |
| Richard Lerner M.D. | 247 Relationships | Director, Member of Scientific Advisory Committee, Member of Human Resources & Compensation Committee and Member of Corporate Governance & Nominating Committee |
Finance Committee* - teva pharmaceutical-sp adr (TEVAN)
| Name(Connections) | Board Relationships | Title |
| Amir Elstein | 58 Relationships | Director, Chairman of Corporate Responsibility Committee, Member of Finance & Invesment Committee and Member of Corporate Governance & Nominating Committee |
| Chaim Hurvitz | 16 Relationships | Director, Member of Finance & Invesment Committee and Member of Corporate Responsibility Committee |
| Galia Maor | 24 Relationships | Director and Chairman of Finance & Invesment Committee |
| Joseph Nitzani | 16 Relationships | Statutory Independent Director, Chairman of Audit Committee, Member of Corporate Governance & Nominating Committee, Member of Human Resources & Compensation Committee, Member of Finance & Invesment Committee and Member of Corporate Responsibility Committee |
| Yitzhak Peterburg M.D., Dr.P.H., MSc | 41 Relationships | Director, Member of Scientific Advisory Committee and Member of Finance & Invesment Committee |
| Dan Suesskind | 93 Relationships | Director, Member of Finance & Invesment Committee and Member of Corporate Responsibility Committee |
| Erez Vigodman | 16 Relationships | Director, Member of Finance & Invesment Committee and Member of Audit Committee |
| Debt To Total Capitalization | 35.7x |
It is important for the finance committee to know when to issue debt or equity.
*Data is at least as current as the most recent Definitive Proxy.
| Recently Viewed | |||
| TEVAN:MM | $497.00 MXN | 0.00 |  |
| Company | Last | Change |
| AbbVie Inc | $46.59 USD | -0.17 |
| Baxter International Inc | $71.82 USD | -0.48 |
| Covidien PLC | $65.29 USD | +0.04 |
| Eli Lilly & Co | $54.90 USD | -0.02 |
| Johnson Matthey PLC | 2,639 GBp | -48.00 |
| View Industry Companies | ||
Industry Analysis
TEVAN
Industry Average
| Valuation | TEVAN | Industry Range |
| Price/Earnings | 20.1x |
|
| Price/Sales | 1.7x |
|
| Price/Book | 1.5x |
|
| Price/Cash Flow | 21.9x |
|
| TEV/Sales | 1.2x |
|
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
